BD Biosciences, a segment of BD , a leading global medical technology company, today announced the launch of the BD FACSPresto Near Patient CD4 Counter system that provides absolute and percentage results of CD4 T lymphocytes and hemoglobin concentration in whole blood samples to stage and monitor HIV/AIDS patients.
http://ift.tt/1lMBwbk
http://ift.tt/1lMBwbk
No comments:
Post a Comment